[Artículo traducido] Inmunoterapia en cáncer de endometrio avanzado con inestabilidad de microsatélites: revisión sistemática

The efficacy of pembrolizumab and pembrolizumab-lenvatinib regimen appears promising. However, studies with larger sample size, longer follow-up and comparative design with subgroup analysis based on differences in microsatellite repair mechanisms are needed for proper therapeutic positioning.